1. FRI0191 Immunogenicity is low and transient with intravenous abatacept therapy. (23rd January 2014) Authors: Weinblatt, M.E.; Genovese, M.C.; Schiff, M.H.; Westhovens, R.; Alten, R.; Delaet, I.; Nys, M.; Manning, J.; Kremer, J.M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0215 Subcutaneous Abatacept in Patients with Polyarticular Juvenile Idiopathic Arthritis and Inadequate Response To Biologic or Non-Biologic Disease-Modifying Antirheumatic Drugs: Pharmacokinetics, Efficacy and Safety. (15th July 2016) Authors: Ruperto, N.; Lovell, D.J.; Tzaribachev, N.; Vega-Cornejo, G.; Louw, I.; Berman, A.; Calvo, I.; Cuttica, R.; Horneff, G.; Avila-Zapata, F.; Anton, J.; Viola, D.; Foeldvari, I.; Keltsev, V.; Kingsbury, D.; Li, X.; Nys, M.; Wong, R.; Banerjee, S.; Martini, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Possible in vivo tolerance of human polymorphonuclear neutrophil to low-grade exercise-induced endotoxaemia. Issue 6 (1998) Authors: Camus, G.; Nys, M.; Poortmans, J-R.; Venneman, I.; Monfils, T.; Deby-Dupont, G.; Juchmés-Ferir, A.; Deby, C.; Lamy, M.; Duchateau, J. Journal: Mediators of inflammation Issue: Volume 7:Issue 6(1998) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0160 THE EFFECT OF HLA-DRB1 RISK ALLELES ON THE CLINICAL EFFICACY AND SAFETY OF ABATACEPT IN SEROPOSITIVE, BIOLOGIC-NAÏVE PATIENTS WITH EARLY, MODERATE-TO-SEVERE RA TREATED WITH ABATACEPT OR ADALIMUMAB: DATA FROM THE OPEN-LABEL SWITCH PERIOD OF THE HEAD-TO-HEAD SINGLE-BLINDED 'EARLY AMPLE' TRIAL. (2nd June 2020) Authors: Rigby, W.; Buckner, J.; Bridges, Jr., S. L.; Nys, M.; Gao, S.; Polinsky, M.; Ray, N.; Bykerk, V. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0497 MAINTENANCE OF MINIMAL DISEASE ACTIVITY OR INACTIVE DISEASE STATUS AND PATIENT-REPORTED OUTCOMES IN INDIVIDUAL PAEDIATRIC PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH SUBCUTANEOUS ABATACEPT. (2nd June 2020) Authors: Brunner, H.; Tzaribachev, N.; Louw, I.; Calvo, I.; Zapata, F.; Horneff, G.; Foeldvari, I.; Kingsbury, D.; Gastanaga, M.; Wouters, C.; Breedt, J.; Wong, R.; Nys, M.; Askelson, M.; Zhuo, J.; Martini, A.; Lovell, D. J.; Ruperto, N. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0549 Absence of association between drug exposure and infection in patients with polyarticular-course juvenile idiopathic arthritis and inadequate response to biologic or non-biologic dmards treated with sc and iv abatacept. (12th June 2018) Authors: Ruperto, N.; Brunner, H.; Tzaribachev, N.; Louw, I.; Calvo, I.; Horneff, G.; Henrickson, M.; Rama, M.E.; Fischbach, M.; Miraval, T.; Ally, M.M.; Li, X.; Wong, R.; Nys, M.; Murthy, B.; Lin, K.; Passarell, J.A.; Martini, A.; Lovell, D.J. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗